|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 January 2002, Vol. 99, No. 2, pp. 709-712
BRIEF REPORT
Lentiviral gene transfer into peripheral blood-derived
CD34+ NOD/SCID-repopulating cells
Michaela Scherr,
Karin Battmer,
Ulrike Blömer,
Bernd Schiedlmeier,
Arnold Ganser,
Manuel Grez, and
Matthias Eder
From the Hannover Medical School, Department Hematology
and Oncology, Hannover, Germany; Heinrich-Pette Institute, Hamburg,
Germany; and Institute for Biomedical Research, Georg-Speyer-Haus,
Frankfurt, Germany.
This study reports a lentiviral gene transfer protocol for
efficient transduction of adult human peripheral blood
(PB)-derived CD34+ NOD/SCID-repopulating cells (SRCs)
using vesicular stomatitis virus-G protein (VSV-G)-pseudotyped
lentiviruses encoding for enhanced green fluorescence protein
(eGFP). Lentiviral stocks were concentrated by anion exchange
chromatography, and transduction was performed under serum-free
conditions at a multiplicity of infection (MOI) between 3 and 50. Similar transduction efficiencies were achieved in the presence and
absence of cytokines. Transduction of PB-derived CD34+
cells at a MOI of 3 resulted in gene transfer efficiencies into SRCs of
9.2% and 12.0% in the absence and presence of cytokines, respectively. Using improved lentiviral vectors, transduction frequency
varied between 42.0% (MOI 10) and 36.0% (MOI 50) with multilineage
transgene expression within SRC-derived myeloid and lymphoid cells. The
protocol described can be adapted for clinical application of
lentiviral gene transfer into PB-derived CD34+ cells from
adult patients.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Tesio, L. Gammaitoni, M. Gunetti, V. Leuci, Y. Pignochino, N. Jordaney, S. Capellero, C. Cammarata, L. Caione, G. Migliaretti, et al.
Sustained Long-Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors
Stem Cells,
June 1, 2008;
26(6):
1620 - 1627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Venturini, K. Battmer, M. Castoldi, B. Schultheis, A. Hochhaus, M. U. Muckenthaler, A. Ganser, M. Eder, and M. Scherr
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Blood,
May 15, 2007;
109(10):
4399 - 4405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nagel, C. Burek, L. Venturini, M. Scherr, H. Quentmeier, C. Meyer, A. Rosenwald, H. G. Drexler, and R. A. F. MacLeod
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1
Blood,
April 1, 2007;
109(7):
3015 - 3023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nagel, M. Scherr, A. Kel, K. Hornischer, G. E. Crawford, M. Kaufmann, C. Meyer, H. G. Drexler, and R. A.F. MacLeod
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-Cell Acute Lymphoblastic Leukemia by Remote 3'-BCL11B Enhancers and Coregulation by PU.1 and HMGA1
Cancer Res.,
February 15, 2007;
67(4):
1461 - 1471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Scherr, A. Chaturvedi, K. Battmer, I. Dallmann, B. Schultheis, A. Ganser, and M. Eder
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)
Blood,
April 15, 2006;
107(8):
3279 - 3287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Morris, M. Conerly, B. Thomasson, J. Storek, S. R. Riddell, and H.-P. Kiem
Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning
Blood,
January 15, 2004;
103(2):
492 - 499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Geronimi, E. Richard, I. Redonnet-Vernhet, I. Lamrissi-Garcia, M. Lalanne, C. Ged, F. Moreau-Gaudry, and H. de Verneuil
Highly Efficient Lentiviral Gene Transfer in CD34+ and CD34+/38-/lin- Cells from Mobilized Peripheral Blood after Cytokine Prestimulation
Stem Cells,
July 1, 2003;
21(4):
472 - 480.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Baum, J. Dullmann, Z. Li, B. Fehse, J. Meyer, D. A. Williams, and C. von Kalle
Side effects of retroviral gene transfer into hematopoietic stem cells
Blood,
March 15, 2003;
101(6):
2099 - 2113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Scherr, K. Battmer, T. Winkler, O. Heidenreich, A. Ganser, and M. Eder
Specific inhibition of bcr-abl gene expression by small interfering RNA
Blood,
February 15, 2003;
101(4):
1566 - 1569.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Horn, M. S. Topp, J. C. Morris, S. R. Riddell, and H.-P. Kiem
Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells
Blood,
December 1, 2002;
100(12):
3960 - 3967.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
